Understanding the age gap in leukemia survival rates

Acute lymphoblastic leukemia (ALL) affects both children and adults, but children have better chances to be cured, with long-term survival rates over 85% compared to 50-75% in adults. Scientists at St. Jude Children’s Research Hospital conducted a comprehensive study to understand the biological causes driving this difference. The work, published today in the Journal of Clinical Oncology, provides a blueprint for understanding B-cell acute lymphoblastic leukemia (B-ALL), the most common form of the disease.

SetSet Launches Clinician-Approved Platform to Deliver Safe Psychedelic Experiences for Women

What You Should Know: – SetSet, the pioneering platform connecting consumers and medical providers for safe microdosing, has officially launched. – The innovative platform is

September 20, 2024

Shingrix Tied to Higher Risk of Ophthalmic Shingles Recurrence

The recombinant zoster vaccine (RZV; Shingrix) was associated with a significantly increased risk of recurrence of herpes zoster ophthalmicus (HZO), according to a retrospective cohort

February 16, 2024

Risk adjusted net present value: What is the current valuation of Kissei Pharmaceutical’s Cretostimogene Grenadenorepvec?

Cretostimogene Grenadenorepvec is an oncolytic virus commercialized by Kissei Pharmaceutical, with a leading Phase III program in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.